Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2010, Vol. 06 ›› Issue (04): 255 -258. doi: 10.3877/cma.j.issn.1673-5250.2010.04.009

Original Article

Relationship of Neonatal High Blood Thyroid-Stimulating Hormone and Their Mother's Thyroid Function

Ming-qiang SUN, Yu-lan ZHOU, Yong YAN, Su-li WANG, Shu-xia ZHANG, Wei-bing TIAN, Yan XU, Jin-long LIU   

  1. Maternal and Child Health Hospital of Weifang City, Weifang 261011, Shangdong Province, China
  • Published:2010-08-01
  • Supported by:
    *Project No.2009-032, supported by the Annual Medical Development Science Projects of Weifang City
Objective

To explore the relationship between neonatal blood thyroid-stimulating hormone (TSH) and maternal thyroid function.

Methods

From May 2000 to August 2009, 615 767 newborns in Weifang City have been screened congenital hypothyroidism (CH) by detecting TSH value of dried blood spots in the Newborn Screening Centre of Weifang City. A total of 195 cases (0.32 ‰, 195/615 767) were diagnosed as CH. Among them, 159 pairs of CH-positive children and their mothers were included in to group A, other 986 pairs of suspected CH children (TSH≥ 15 μIU/mL) and their mothers (not including the CH-positive children) were included into group B. At the same time, 225 pairs of normal children and their mothers who received screening were recruited into control group. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Maternal and Child Health Hospital of Weifang City. Informed consent was obtained from all participants. Mothers in each group excluded patients with abnormal thyroid function and other diseases that may cause thyroid dysfunction. Detected newborn dried blood TSH value to screening for CH. Collected mother's venous blood (2 mL) when the newborn's TSH≥15 μIU/mL, then analyzed the relationship between mother's thyroid function change trend and their newborn's elevated serum TSH by electrochemiluminescence immunoassay system, including maternal serum TSH, total triiodo thyronine(TT3), total thyroxine (TT4), free triiodo thyronine(FT3), free thyroxine (FT4), thyroid peroxidase antibody(TPO-Ab), thyroglobulin (TG), thyroglobulin antibody(TG-Ab).

Results

①The thyroid dysfunction of mother in group A was 23.3% (37/159), group B was 7.00% (69/986), and control group was 1.78% (4/225). The difference was significant among three groups by chi-square test (P<0.01). ② There was significant difference of TSH, TPO-Ab, TG and TG-Ab of mother's in group A, B and control group (P<0.01). ③ The incensement of neonatal blood TSH was related to the exception of their mother's TSH, TPO-Ab, TG and TG-Ab (P<0.01). ④Statistical analysis showed that the incidence of CH was positively correlated with the abnormal of mother's TSH (r=0.205), FT3 (r=0.127), FT4 (r=0.206), TPO-Ab (r=0.292), TG (r=0.214), TG-Ab (r=0.236) and was no correlated with mother's TT3 (r=0.015), TT4 (r=0.065).

Conclusion

①The incensement of neonatal blood TSH was related to their mother's thyroid dysfunction. ②The newborn elevated TSH was positively correlated with the abnormal of mother's TSH, TPO-Ab, TG and TG-Ab. ③Mother thyroid dysfunction could lead to neonatal CH.

1 Liang L, Jiang XY, Qu YP, et al.Influence of mother's AITD on offspring[J].Clin J Pediatr, 2003, 21(7): 401-402.[梁黎,蒋优君,曲一平,等.母亲患自身免疫性甲状腺疾病对婴儿的影响[J].临床儿科杂志,2003, 21(7): 401-402.]
2 Peter F. Thyroid dysfunction in the offspring of mothers with autoimmune thyroid diseases[J]. Acta Pediatr, 2005, 94: 1008-1010.
3 Yeo CP, Khoo DH, Eng PH, et al. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: Correlations with total and free beta human chorionic gonadotrophin[J]. Clin Endocrinol, 2001, 55: 391-398.
4 Allan WC. Maternal thyroid deficiency and pregnancy complications: Implications for population screening[J]. J Med Screen, 2000, 7: 127-130.
5 Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child[J]. N Engl J Med, 1999, 341: 549-555.
6 Ghafoor F, Mansoor M, Malik T, et al. Role of thyroid peroxidase antibodies in the outcome of pregnancy[J]. J Coll Physician Surg Pak, 2006, 16(7): 468-471.
7 Poppe KG. Thyroid autoimmunity and hypothyroidism before and during pregnancy[J]. Hum Reprod Update, 2003, 149-161.
8 Li CY, Teng WP, Shang T.Thyroid autoimmunity and pregnancy[J].Chin J Internal Med, 2003, 3(6): 441-443.[李晨阳,藤卫平,尚涛.甲状腺自身免疫与妊娠[J].中华内科杂志,2003, 3(6): 441-443.]
9 Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes [J]. Obstet Gynecol, 2005, 105 (2): 239-240.
10 Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 199922002) [J]. Thyroid, 2007, 17(12): 1211-1223.
11 Jiang YJ, Liang L, Zhu H, et al.Risk factors of thyroid dysfunction in early infants born to mothers with autoimmune thyroid disease[J].Chin J Endocrin Metab, 2004, 20(14): 307-310.[蒋优君,梁黎,朱红,等.孕母自身免疫性甲状腺疾病对婴儿甲状腺功能的多因素分析[J].中华内分泌代谢杂志,2004, 20(14): 307-310.]
12 Li CY, Guan HX, Li YM.The prospective clinical epidemiological investigation of postpartum thyroid inflammation[J].Chin J Endocrin Metab, 2005, 21(2): 99-102.[李晨阳,关海霞,李玉妹.产后甲状腺炎的前瞻性临床流行病学调查[J].中华内分泌代谢杂志,2005, 21(2): 99-102.]
13 Zeng ZJ, Jiang T, Ouyang WT. The diagnostic value of thyroid peroxidase antibodies in pregnancy dysfunction[J]. Int J Lab Med, 2006, 27(3): 199-202.[曾志杰,姜傥,欧阳文婷.过氧化物酶抗体在妊娠甲状腺功能紊乱发生中的诊断价值[J].国际检验医学杂志,2006, 27(3): 199-202.]
14 Lao TT. Thyroid disorders in pregnancy[J]. Curr Opin Obstet Gynecol, 2005, 17: 123-127.
15 Mitchell ML, Klein RZ. The sequelae of untreated maternal hypothyroidism [J]. Eur J Endocrinol, 2004, 151(Supp l3): U45-48.
[1] Wei Hong, Xirong Ye, Zhihong Liu, Yinfeng Yang, Zhihong Lyu. Value of ultrasound radiomics combined with clinicopathological features in predicting complete pathological response to neoadjuvant chemotherapy for breast cancer[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(06): 571-579.
[2] Xiaoyu Zhang, Yulai Yin, Yinxu Zhang. Efficacy and prognostic analysis of apatinib combined with neoadjuvant chemotherapy in triple negative breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2024, 18(06): 346-352.
[3] Shengjun Nie, Yu Wang, Yi Wang, Xiaoqing Xian, Shengcheng Ma. Clinical effect observation of compound betamethasone local injection combined with photodynamic therapy for small keloids[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(05): 404-410.
[4] Junying Gao, Haizhou Zhang, Hongle Qu, Qiang Sun. Progress in the application of FOLFOX-HAIC-based adjuvant translational therapy for hepatocellular carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(06): 457-463.
[5] Jie Xu, Yajun Li, Yiwen Feng. Comparison of recent follow-up between laparoscopic D2 radical surgery and conventional radical surgery for advanced gastric cancer after SOX neoadjuvant chemotherapy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 647-650.
[6] Qing Xue, Saiye Shi, Yawen Xu, Xia Sheng, Qinqin Zhang. Application of tracking methodology combined with failure mode and effect analysis in patients with bladder perfusion chemotherapy[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 553-559.
[7] Hao Zhang, Weidong Pan. Current status and progress in assessment of resectability of pancreatic cancer after neoadjuvant chemotherapy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 629-633.
[8] Junhua Wang, Ruixuan Wang. Current status and treatment strategy of neoadjuvant chemotherapy for pancreatic cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 640-643.
[9] Miaoyan Wei, Jin Xu. Progress and prospects of systemic treatment for pancreatic cancer with distant metastasis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 644-650.
[10] Lei Zhao, Wenzhi Liu, Feng Lin, Jian Yu, Mingjun Sun, Yougang Cui, Xu Zhang, Yupeng Yi, Baosheng Yu, Ning Feng. The study on the effects of deep hyperthermia in improving side effects of adjuvant chemotherapy and quality of life in the patients after colorectal cancer surgery[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 488-493.
[11] Jiagang Han, Zhenjun Wang. The treatment strategies for obstructive left-sided colon cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 450-458.
[12] Yang Shi, Jianfeng Yu, Ke Cao, Zhiwei Zhai, Chunxiang Ye, Zhenjun Wang, Jiagang Han. Perioperative complication analysis of self-expanding metallic stents (sems) combined with neoadjuvant chemotherapy in the treatment of complete obstructive left-sided colon cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 464-471.
[13] Xuanhao Liang, Xiaorong Li, Liang Li, Changwei Lin. Efficacy and prognosis of colonic stenting combined with neoadjuvant chemotherapy for acute obstructive colorectal cancer: a Meta-analysis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 472-482.
[14] Ying Zhang, Xin Zhao, Jiamei Chen, Yan Li. Impact of preoperative chemotherapy on prognosis of pseudomyxoma peritonei treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy:a meta-analysis[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 826-835.
[15] Mengting Zhang, Lamu Qiong, Zhen Se, Yiqun Li, Wangmu DeQing. Neoadjuvant chemotherapy for breast cancer patients in Tibet: a real-world study[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 441-446.
Viewed
Full text
0
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 0


Abstract
16
Just accepted Online first Issue
0 0 16
  From Others local
  Times 15 1
  Rate 94% 6%